Navigation Links
Nucletron Announces Oncentra(R) Brachy* Treatment Planning Solution for Multimodality Environment
Date:4/28/2008

VEENENDAAL, The Netherlands, April 28 /PRNewswire/ --

- New Anatomy-Based Solution for HDR/PDR Brachytherapy Represents the Next Generation in DICOM-Compatible, Integrated Cancer Treatment Planning

Nucletron, a knowledge-based leader in radiation oncology, today announced the introduction of Oncentra(R) Brachy*, a comprehensive volume-based treatment planning system to optimize cancer treatment planning with brachytherapy. Oncentra Brachy, the world's first fully DICOM-compatible treatment planning system, features state-of-the-art optimization algorithms to ensure efficient treatment. The new solution provides excellent 3D contouring and margining tools to identify Regions of Interests (ROIs) on CT or in a multimodality imaging environments using image registration for CT, MR and PET data.

Oncentra Brachy provides many benefits to clinicians allowing for faster and easier creation of treatment plans, ranging from simple to complex, in user-defined workspaces that allow for adaptation to specific clinical workflows. Real-time information-sharing provides immediate access for the entire medical team and facilitates the exchange of treatment plans over vast distances with decentralized planning capabilities. Physicians are able to evaluate and authorize treatment plans remotely.

"The release of Oncentra Brachy marks the first of some new and exciting treatment planning innovations forthcoming from Nucletron," said Jeroen Cammeraat, chief operating officer of Nucletron. "We have set a new benchmark in technological achievement with Oncentra Brachy that represents the future of brachytherapy treatment planning. We have worked with our clinical partners to develop a state-of-the art solution that includes many sophisticated and powerful new tools to improve patient care."

"Oncentra Brachy opens new possibilities to explore new treatment techniques for brachytherapy planning that could not be considered before," according to the r
'/>"/>

SOURCE Nucletron B V
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
2. Alfacell Announces Retirement of Chief Executive Officer
3. Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing
4. Exelixis Announces May 6 Webcast of Its First Quarter 2008 Financial Results and Business Update Conference Call
5. ATS Medical Announces First Quarter 2008 Earnings Release Date and Conference Call
6. Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date
7. IDEXX Laboratories Announces First Quarter Results
8. Kosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results
9. Exelixis Announces April 30 Webcast of Presentation at the Morgan Stanley Global Healthcare Unplugged Conference
10. ETEX Announces Supply Agreement with AlloSource
11. Wyeth Chairman Robert Essner Announces June 27 Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...FirstCall/ -- Eli Lilly and,Company (NYSE: LLY ) ...ion,of SGX Pharmaceuticals, Inc. (Nasdaq: SGXP ),...n drug discovery and development in the area,of on...s Special,Stockholders Meeting, in which a majorit... agreement with Lilly. Under the agreement, Lilly ...
(Date:8/20/2008)... and Caregivers, Grassroots ...ewswire-USNewswire/ -- Inc. Magazine has,named Sen...an for,low-income seniors, the number one fastest-...rt of Inc.,s annual list of the country,s 500 fast...1,000 percent from 2004 to 2007., "This is a rewa...
(Date:8/20/2008)...ll/ -- CEL-SCI CORPORATION,(Amex: CVM ) reports f...ing,June 30, 2008., The Company,s loss from opera...76,679 versus a loss of $3,776,263 during the same...ns for the nine months ended June 30, 2008,was $7,...e nine months in,2007., The net loss per common s...
(Date:8/20/2008).../ -- Huifeng Bio-Pharmaceutical,Technology, Inc (O...producer of plant extracts and pharmaceutical raw ... and food production, today announced it will,be i... August 19-21 in Rio,de Janeiro, Brazil., "Unpara...volved in the,pharmaceutical raw materials industr...
Breaking Biology Technology:Lilly Announces Completion of SGX Acquisition 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 2Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 2CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 3CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 4CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results 5Huifeng Bio-Pharmaceutical (HFGB) to Attend CPhI South America 2008 Pharmaceutical Conference; The First CPhI Conference to be held in the Emerging Market of Brazil 2
... During many experiments in molecular biology, t...a cell is examined in order to investigate the rea...uch as viral infections or medical treatment. , ...horoughly, it is converted , to cDNA. If ..., the result , is referred to as a "cDNA ...
... , Guy Adami, Department of Oral Medicin...SA , Vincent Prezioso, Eppendorf Scientif... Introduction , , Transgenic ... incorporated , into their genome. The mo..., into the mouse genome is by microinjectio...
..., George Halley and Vincent Prezioso, PhD ,...lder, CO, USA , Vincent Prezioso, Brinkmann... , NY , , Abstract , ...ular because of their convenience , and t...Typical Hot Start , enzymes utilize chemi...
... Multiporator / Electroporator 2510 , , ... Transformation Protocol , P... , , , , , , , ,... Ustilago maydis fbd11, protoplasts, ... Phytopathogenic fungus, yeast-like growing spo...
Other Biology Technology:Normalizing cDNA libraries using the EppendorfThermomixer 2Normalizing cDNA libraries using the EppendorfThermomixer 3Normalizing cDNA libraries using the EppendorfThermomixer 4The use of TaqMaster PCR Enhancer 2The use of TaqMaster PCR Enhancer 3The use of TaqMaster PCR Enhancer 4The use of TaqMaster PCR Enhancer 5HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 2HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 3HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 4HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 5HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 6HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 7Ustilago maydis 2Ustilago maydis 3
(Date:8/20/2008)...mers called polyketals and their derivatives may i...s acute lung injury, acute liver failure and infla...s and snips of ribonucleic acid to disease locatio...we developed are simply a vehicle to get the drugs...s possible," said Niren Murthy, assistant professo...
(Date:8/20/2008)...ue of the Journal of Lipid Research suggests an ... rising rate of diabetes, especially in children a...he primary mechanism of inheritance; kids get half...scientists are just starting to understand additio...g, which occurs when an insult during a critical p...
(Date:8/19/2008)...lahoma researchers began studying the environmenta...ued the energy industry for decades, they did not ...rganisms capable of converting hydrocarbons into n...oundbreaking processknown as anaerobic hydrocarbon...oduction from older, more mature oil reservoirs li...
(Date:8/19/2008)...versity has received a $3.2 million grant from the...ering, physical science and mathematical disciplin...ellowships, the program can equip experts in field...l modeling and biomaterials to move stem-cell brea...commercially viable therapies. , NSF awarded the...
Breaking Biology News(10 mins):Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 2Biodegradable polymers show promise for improving treatment of acute inflammatory diseases 3OU researchers isolate microorganisms that convert hydrocarbons to natural gas 2OU researchers isolate microorganisms that convert hydrocarbons to natural gas 3$3.2M for Rutgers to apply biology, engineering, physical sciences toward stem cells 2$3.2M for Rutgers to apply biology, engineering, physical sciences toward stem cells 3Seeing our spouses more negatively might be a positive 11022 1Seeing our spouses more negatively might be a positive 11022 2West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 11019 1West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 11019 2AST to Address New Concept in Organ Allocation at March 13 16 Winter Symposium 11014 1AST to Address New Concept in Organ Allocation at March 13 16 Winter Symposium 11014 2Picture This 3A Heart Health Risk Assessment Gets Easier 11012 1Picture This 3A Heart Health Risk Assessment Gets Easier 11012 2Picture This 3A Heart Health Risk Assessment Gets Easier 11012 3
...Max Planck researchers sequence the genome of a mi...ingle-celled organisms, are particularly interesti...der extreme environmental conditions, for instance...r high temperatures. Nature,s masters of adaptatio... can draw conclusions about the first organisms on...
...A new study suggests that restoring a gene often s...struct. The findings could lead to a new strategy ...on a gene known as WWOX, which is lost or silenced...rs of the breast, ovary, prostate, bladder, esopha...t The Ohio State University Comprehensive Cancer C...
...Human activities are degrading the Amazonian fores... a new study that adds the effects of logging to t... 21 October issue of the journal Science , publis...l now, satellite-based methods for measuring defor... of detecting clear-cut swaths of land, where all ...
...The survival rate of HIV-infected patients in Indi...rice of antiretroviral therapy (ART), according to...tious Diseases, now available online. The introduc...ged people to seek HIV treatment because of the ch... than 5 million HIV-infected people living in Indi...
Other Biology News:Life in deadly conditions 2Life in deadly conditions 3Restoring silenced suppressor gene kills lung-cancer cells 2Logging doubles threat to the Amazon, rivaling clear-cutting, study suggests 2HIV mortality in India drops with introduction of generic antiretroviral therapy 2
ANXA11 Immunogen: ANXA11 (NP_001148, 406 a.a. ~ 506 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Anti-Flavocytochrome b Monoclonal, FITC Labeled Research Focus: other Storage: 4C Shipping Temperature: 4C
Rabbit polyclonal to MKK6 (phospho S207) ( Abpromise for all tested applications). Antigen: Synthetic phosphopeptide derived from human MKK6 around the phosphorylation site of Serine 207 (V-D-S
Mouse monoclonal [1Q17] to TGE Virus peplomer ( Abpromise for all tested applications).
Biology Products: